sar425899 glucagon glp-1 dual agonist sanofi The current significance and prospects for the use of receptor agonism GLP-1/Glucagon Role of a Dual Glucose-Dependent

Ozempic alternatives for weight loss span branded medications, compounded formulations, and lifestyle-based approaches

225 mg of Hericium erinaceus extract (equivalent to 1.8 g of dried mushroom), titrated to 30% polysaccharides

Society guidelines have left clinicians with some questionable recommendations

Evidence-based comparison of retatrutide (GIP/GLP-1/glucagon triple agonist) and survodutide (GLP-1/glucagon dual agonist) for weight loss, MASH, and metabolic disease based on Phase 2 clinical trial data.

Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care

Our blog series on GLP-1 agonists for weight loss is aimed at unpacking the science behind this new frontier in weight management, presenting a detailed overview of how they work, their efficacy, and their role in a holistic approach to health and wellness.